{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:27:25Z","timestamp":1791073645734,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.vaccine.2009.01.137","type":"journal-article","created":{"date-parts":[[2009,3,7]],"date-time":"2009-03-07T09:24:34Z","timestamp":1236417874000},"page":"4370-4380","source":"Crossref","is-referenced-by-count":43,"title":["Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII"],"prefix":"10.1016","volume":"27","author":[{"given":"Mathura P.","family":"Ramanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele A.","family":"Kutzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Chia","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidhi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrit","family":"Bawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Selling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niranjan Y.","family":"Sardesai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Joseph","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2009.01.137_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00019052-200306000-00023","article-title":"Exotic and emerging viral encephalitides","volume":"16","author":"Solomon","year":"2003","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.137_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/13550280390194037","article-title":"Recent advances in Japanese encephalitis","volume":"9","author":"Solomon","year":"2003","journal-title":"J Neurovirol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.01.137_bib3","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1046\/j.1537-2995.2003.00481.x","article-title":"West Nile virus infection transmitted by blood transfusion","volume":"43","author":"Harrington","year":"2003","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.137_bib4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0003-4975(03)00271-6","article-title":"A case of fatal West Nile virus meningoencephalitis associated with receipt of blood transfusions after open heart surgery","volume":"76","author":"Armstrong","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.vaccine.2009.01.137_bib5","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1600-6143.2004.00410.x","article-title":"West Nile virus encephalitis in a kidney transplant recipient","volume":"4","author":"Shepherd","year":"2004","journal-title":"Am J Transplant"},{"issue":"13","key":"10.1016\/j.vaccine.2009.01.137_bib6","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJMoa030969","article-title":"Transmission of West Nile virus through blood transfusion in the United States in 2002","volume":"349","author":"Pealer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.01.137_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.micro.56.012302.160654","article-title":"The molecular biology of West Nile Virus: a new invader of the western hemisphere","volume":"56","author":"Brinton","year":"2002","journal-title":"Ann Rev Microbial"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.137_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/505121","article-title":"Clinical features in children hospitalized during the 2005 epidemic of Japanese encephalitis in Uttar Pradesh, India","volume":"43","author":"Kumar","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2009.01.137_bib9","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1212\/WNL.57.12.2313","article-title":"Persistent movement disorders following Japanese encephalitis","volume":"57","author":"Murgod","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2009.01.137_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0065-3527(03)61003-1","article-title":"Japanese encephalitis","volume":"61","author":"Halstead","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2009.01.137_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004263.pub2","article-title":"Vaccines for preventing Japanese encephalitis","volume":"3","author":"Schioler","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2009.01.137_bib12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.micinf.2005.05.023","article-title":"Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis","volume":"8","author":"Appaiahgari","year":"2006","journal-title":"Microbes Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.137_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14787210.4.2.313","article-title":"Japanese encephalitis: development of new candidate vaccines","volume":"4","author":"Bharati","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"10","key":"10.1016\/j.vaccine.2009.01.137_bib14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.vaccine.2009.01.137_bib15","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/S0264-410X(00)00111-0","article-title":"Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States.","volume":"18","author":"Takahashi","year":"2000","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.01.137_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jns.2007.06.041","article-title":"Japanese encephalitis revisited","volume":"262","author":"Diagana","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.vaccine.2009.01.137_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of flaviviruses","volume":"59","author":"Lindenbach","year":"2003","journal-title":"Adv Virus Res"},{"issue":"10","key":"10.1016\/j.vaccine.2009.01.137_bib18","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1128\/JVI.65.10.5579-5583.1991","article-title":"The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization","volume":"65","author":"Heinz","year":"1991","journal-title":"J Virol"},{"issue":"7059","key":"10.1016\/j.vaccine.2009.01.137_bib19","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vaccine.2009.01.137_bib20","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nm1240","article-title":"Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus","volume":"11","author":"Oliphant","year":"2005","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.01.137_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virusres.2008.02.008","article-title":"DC-SIGN enhances infection of cells with glycosylated West Nile virusin vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha","volume":"135","author":"Martina","year":"2008","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.137_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vaccine.2007.10.055","article-title":"Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus","volume":"26","author":"Martina","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2009.01.137_bib23","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.178.5.2699","article-title":"Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile virus infection","volume":"178","author":"Chu","year":"2007","journal-title":"J Immunol"},{"issue":"26","key":"10.1016\/j.vaccine.2009.01.137_bib24","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1016\/j.vaccine.2004.12.028","article-title":"Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein","volume":"23","author":"Mota","year":"2005","journal-title":"Vaccine"},{"issue":"Pt 8","key":"10.1016\/j.vaccine.2009.01.137_bib25","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1099\/0022-1317-70-8-2037","article-title":"Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein","volume":"70","author":"Mason","year":"1989","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.01.137_bib26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00430-007-0043-4","article-title":"Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice","volume":"196","author":"Alka","year":"2007","journal-title":"Med Microbiol Immunol"},{"issue":"5577","key":"10.1016\/j.vaccine.2009.01.137_bib27","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.1070441","article-title":"Diversity considerations in HIV-1 vaccine selection","volume":"296","author":"Gaschen","year":"2002","journal-title":"Science (New York, NY)"},{"issue":"2","key":"10.1016\/j.vaccine.2009.01.137_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.mt.6300036","article-title":"Enhanced cellular immune responses elicited by an engineered HIV-1 subtype B consensus-based envelope DNA vaccine","volume":"15","author":"Yan","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2009.01.137_bib29","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1128\/JVI.02335-08","article-title":"Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus","volume":"83","author":"Laddy","year":"2009","journal-title":"J Virol"},{"issue":"40","key":"10.1016\/j.vaccine.2009.01.137_bib30","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1016\/j.vaccine.2008.03.060","article-title":"Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus","volume":"26","author":"Muthumani","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.01.137_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/dna.2006.25.383","article-title":"Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct","volume":"25","author":"Kumar","year":"2006","journal-title":"DNA Cell Biol"},{"issue":"40","key":"10.1016\/j.vaccine.2009.01.137_bib32","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/j.vaccine.2008.03.069","article-title":"Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6\/E7 fusion consensus protein in mice and rhesus macaques","volume":"26","author":"Yan","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.01.137_bib33","doi-asserted-by":"crossref","first-page":"e2517","DOI":"10.1371\/journal.pone.0002517","article-title":"Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens","volume":"3","author":"Laddy","year":"2008","journal-title":"PLoS ONE"},{"issue":"40","key":"10.1016\/j.vaccine.2009.01.137_bib34","doi-asserted-by":"crossref","first-page":"5230","DOI":"10.1016\/j.vaccine.2008.03.071","article-title":"Parameters for DNA vaccination using adaptive constant-current electroporation in mouse and pig models","volume":"26","author":"Draghia-Akli","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.01.137_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1096\/fj.04-2633com","article-title":"A novel autoregulatory mechanism for transcriptional activation of the IL-15 gene by a nonsecretable isoform of IL-15 generated by alternative splicing","volume":"19","author":"Nishimura","year":"2005","journal-title":"Faseb J"},{"issue":"6","key":"10.1016\/j.vaccine.2009.01.137_bib36","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.4049\/jimmunol.174.6.3590","article-title":"A novel role of IL-15 in early activation of memory CD8+ CTL after reinfection","volume":"174","author":"Yajima","year":"2005","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.01.137_bib37","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.cgt.7700973","article-title":"Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation","volume":"13","author":"Ugen","year":"2006","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"10.1016\/j.vaccine.2009.01.137_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4049\/jimmunol.175.1.112","article-title":"Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help","volume":"175","author":"Kutzler","year":"2005","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.01.137_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri1052","article-title":"Cytokine control of memory T-cell development and survival","volume":"3","author":"Schluns","year":"2003","journal-title":"Nat Rev"},{"issue":"8","key":"10.1016\/j.vaccine.2009.01.137_bib40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat Rev"},{"issue":"12","key":"10.1016\/j.vaccine.2009.01.137_bib41","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/ni729","article-title":"Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response","volume":"2","author":"Ohteki","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2009.01.137_bib42","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/13550280500385229","article-title":"Expression and evolutionary analysis of West Nile virus (Merion strain)","volume":"11","author":"Ramanathan","year":"2005","journal-title":"J Neurovirol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.01.137_bib43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1708-8305.2007.00134.x","article-title":"Japanese encephalitis for a reference to international travelers","volume":"14","author":"Oya","year":"2007","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2009.01.137_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-2148-7-100","article-title":"A curious coincidence: mosquito biodiversity and the limits of the Japanese encephalitis virus in Australasia","volume":"7","author":"Hemmerter","year":"2007","journal-title":"BMC Evol Biol"},{"issue":"9360","key":"10.1016\/j.vaccine.2009.01.137_bib45","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(03)12709-2","article-title":"Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial","volume":"361","author":"Solomon","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2009.01.137_bib46","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/JVI.77.5.3091-3098.2003","article-title":"Origin and evolution of Japanese encephalitis virus in southeast Asia","volume":"77","author":"Solomon","year":"2003","journal-title":"J Virol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2009.01.137_bib47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0264-410X(00)00039-6","article-title":"Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus","volume":"18","author":"Tsarev","year":"2000","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2009.01.137_bib48","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/j.vaccine.2006.08.008","article-title":"Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis","volume":"25","author":"Watts","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.01.137_bib49","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.vaccine.2006.08.018","article-title":"Preparation and immunogenic properties of a recombinant West Nile subunit vaccine","volume":"25","author":"Lieberman","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09002862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09002862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T13:02:42Z","timestamp":1589634162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09002862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":49,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0264410X09002862"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.137","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}